Clinical Trial: A Phase 1/2 Study to Assess the Safety and Immunogenicity of JCXH-221, an mRNA-based Broadly Protective COVID-19 Vaccine
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A PHASE 1/2 STUDY TO ASSESS THE SAFETY AND IMMUNOGENICITY OF A BROADLY PROTECTIVE mRNA VACCINE JCXH-221 AGAINST SARS-CoV-2 INFECTION AND DISEASES
Brief Summary:
The goal of this clinical trial is to learn about, test, and compare JCXH-221 in healthy volunteers.The main aims to answer are:To assess the safety and tolerability of the JCXH-221 vaccine in healthy adult subjectsTo identify an optimal dose for the JCXH-221 vaccine in healthy adult subjectsTo assess the humoral immunogenicity of the JCXH-221 vaccine in healthy adult subjectsTo characterize the cellular immunogenicity of the JCXH-221 vaccine in healthy adult subjectsParticipants for Phase I will be randomized to…
Read more